St. Jude Medical (NYSE:STJ) said Thursday it paid $16 million to end a government investigation determining whether the company paid doctors who put its heart device in their patients.
The payout ends a 5-year Department of Justice investigation connected to a whistleblower complaint that claimed the company paid kickbacks of up to $2,000 per patient to help market its products. The former St. Jude technician who spurred the investigation said the payments were for fake research studies on the devices.
“The company maintains that its post-market studies and registries are legitimate clinical studies designed to gather important scientific data and St. Jude Medical does not admit liability or wrongdoing by entering into this agreement,” St. Jude Medical said in a statement. “The company entered into a settlement agreement to avoid the potential costs and risks associated with litigation. This settlement brings the previously reported post-market study investigation to a close.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
St. Jude in the middle of last year paid $3.7 million to settled a similar case in which it made illegal payments to hospitals in Kentucky and Ohio that used its heart products.
